OMEROS CORP (OMER) Form 10-K Annual Reports
OMEROS CORP (OMER) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: OMER
CIK: 1285819
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: WA
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerErica Fewel
Audit LocationSeattle, Washington, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-24 | 2026-09-22 | FORM 4 | 0001437749-26-031169 | View SEC Doc Filr Page |
| 144 | 2026-09-23 | — | 144 Filing | 0001950047-26-009769 | View SEC Doc Filr Page |
| 144 | 2026-09-22 | — | 144 Filing | 0001950047-26-009751 | View SEC Doc Filr Page |
| 4 | 2026-09-01 | 2026-08-28 | FORM 4 | 0001437749-26-029427 | View SEC Doc Filr Page |
| 144 | 2026-08-31 | — | 144 Filing | 0001950047-26-008856 | View SEC Doc Filr Page |
| 144 | 2026-08-28 | — | 144 Filing | 0001950047-26-008821 | View SEC Doc Filr Page |
| 4 | 2026-08-28 | 2026-08-26 | FORM 4 | 0001437749-26-029191 | View SEC Doc Filr Page |
| 144 | 2026-08-27 | — | 144 Filing | 0001950047-26-008747 | View SEC Doc Filr Page |
| 144 | 2026-08-26 | — | 144 Filing | 0001950047-26-008714 | View SEC Doc Filr Page |
| 4 | 2026-08-25 | 2026-08-21 | FORM 4 | 0001437749-26-028951 | View SEC Doc Filr Page |
| 4 | 2026-08-21 | 2026-08-20 | FORM 4 | 0001437749-26-028754 | View SEC Doc Filr Page |
| 144 | 2026-08-21 | — | 144 Filing | 0001950047-26-008553 | View SEC Doc Filr Page |
| 144 | 2026-08-20 | — | 144 Filing | 0001950047-26-008458 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-12 | FORM 4 | 0001437749-26-028463 | View SEC Doc Filr Page |
| 3 | 2026-08-18 | 2026-08-12 | FORM 3 | 0001437749-26-028461 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-13 | FORM 4 | 0001437749-26-028229 | View SEC Doc Filr Page |
| 144 | 2026-08-13 | — | 144 Filing | 0001950047-26-008092 | View SEC Doc Filr Page |
| S-8 | 2026-08-13 | — | S-8 Filing | 0001552781-26-000442 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-12 | 8-K Filing | 0001552781-26-000441 | View SEC Doc Filr Page |
| 10-Q | 2026-08-12 | 2026-06-30 | FORM 10-Q | 0001437749-26-027318 | View SEC Doc Filr Page |
| 8-K | 2026-08-12 | 2026-08-12 | FORM 8-K | 0001437749-26-027313 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-29 | — | SCHEDULE 13G/A Filing | 0002012383-26-002918 | View SEC Doc Filr Page |
| 4 | 2026-07-24 | 2026-07-22 | FORM 4 | 0001437749-26-024443 | View SEC Doc Filr Page |
| 4 | 2026-07-24 | 2026-07-22 | FORM 4 | 0001437749-26-024441 | View SEC Doc Filr Page |
| 4 | 2026-07-24 | 2026-07-22 | FORM 4 | 0001437749-26-024439 | View SEC Doc Filr Page |